Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.2%
    Check dated 2025-01-14T19:13:47.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:23:22.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T19:23:04.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The website has removed several links to external resources related to rare diseases and clinical trials, as well as specific sections on participant groups and treatment interventions.
    Difference
    4%
    Check dated 2024-11-23T05:48:21.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    New resources have been added, including links to rare disease information, clinical trial documents, and drug information for Paclitaxel and Pembrolizumab.
    Difference
    0.4%
    Check dated 2024-11-16T01:18:53.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The website has been updated to include new features for downloading study data in various formats and has upgraded to revision v2.12.2, while removing the option to show less information and the previous revision v2.12.1.
    Difference
    4%
    Check dated 2024-11-08T19:05:30.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.